A Phase III Randomized Double-Blinded Study of Nevirapine for the Prevention of Maternal-Fetal Transmission in Pregnant HIV-Infected Women.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Nevirapine (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 03 Apr 2012 Biomarkers information updated
- 29 Sep 2008 Actual end date (Aug 2007) added as reported by ClinicalTrials.gov.
- 29 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.